FDA APPROVAL

Advertisement
Jan 20 2026HEALTH

ADHD Treatment Device Falls Short in New Study

A device approved by the FDA for treating ADHD in children has been found ineffective in a recent clinical trial. The external trigeminal nerve stimulator, which was expected to reduce ADHD symptoms, showed no significant improvement compared to a placebo. The FDA had initially approved the device

reading time less than a minute
Dec 31 2025HEALTH

A New Hope for Motion Sickness Sufferers

The U. S. Food and Drug Administration (FDA) has given the green light to a new drug called Nereus, designed to tackle motion sickness. This approval is a big deal because it's the first new treatment for this condition in over 40 years. The drug, also known as tradipitant, works by blocking a speci

reading time less than a minute
Dec 26 2025HEALTH

Pfizer's Hympavzi Faces Setback: What You Need to Know

Pfizer's stock took a hit recently, and it's all tied to a serious issue with one of their drugs. A patient in a long-term study for Hympavzi, a treatment for hemophilia, passed away due to severe complications. This news came out in December 2025, and it's got people talking. The patient had hemop

reading time less than a minute
Dec 23 2025FINANCE

European Markets Soar: A Closer Look at the Numbers

European markets are on a roll, hitting new highs. The Stoxx 600, DAX, and CAC 40 indexes have all seen significant gains. This year alone, the Stoxx 600 has climbed 14% higher. With just a week left, it's looking like it will be the third year in a row of growth. Investors are keeping a close eye

reading time less than a minute
Dec 16 2025HEALTH

More Women Can Now Use the Libido Drug Addyi

The FDA has recently given the green light to a wider group of women to use Addyi, a drug designed to boost sexual desire. This time, the approval is for postmenopausal women up to 65 years old. Addyi was first introduced a decade ago for premenopausal women dealing with emotional stress due to a lo

reading time less than a minute
Dec 12 2025HEALTH

A New Way to Treat Depression: Electric Stimulation at Home

The FDA has given the green light to a new device that uses gentle electric currents to help people with depression. This device, made by a company called Flow Neuroscience, can be used at home. It's a big deal because it could make treatment more accessible to many people who struggle with depressi

reading time less than a minute
Nov 22 2025HEALTH

A New Hope for Cats Facing a Flesh-Eating Threat

A dangerous parasite, the New World screwworm, has been a concern for cats and other animals. This fly's larvae can burrow into open wounds, causing serious harm. Recently, the U. S. Food and Drug Administration (FDA) took a big step. They allowed a drug called Credelio CAT to be used in an emergenc

reading time less than a minute
Nov 13 2025HEALTH

FDA Speeds Up Approval for Rare Disease Treatments

The FDA has introduced a new approach to get treatments for rare genetic diseases to patients faster. Normally, drugs need to go through big, time-consuming studies. But now, for some serious conditions, smaller studies might be enough. This new method focuses on the science behind the treatment an

reading time less than a minute
Nov 11 2025HEALTH

Navigating Menopause: A Modern Look at Hormone Therapy

Menopause can be a challenging phase, with symptoms like hot flashes, night sweats, and sleep disturbances. Recent updates from the FDA have made hormone therapy more accessible by removing some of the previously alarming warning labels. This shift is based on new research indicating that hormone th

reading time less than a minute
Nov 08 2025HEALTH

Semaglutide: A New Hope for Liver Health in 2025

In 2025, a significant update was made to how doctors treat a liver condition called MASH. This condition is linked to metabolic issues and used to be known as NAFLD. The update focuses on using a drug called semaglutide, which is found in a medication named Wegovy. The FDA gave Wegovy the green li

reading time less than a minute